- Home
- ROOT vs SPRY Comparison
ROOT vs SPRY Comparison
Compare ROOT & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROOT
- SPRY
- Stock Information
- Founded
- ROOT 2015
- SPRY 2015
- Country
- ROOT United States
- SPRY United States
- Employees
- ROOT N/A
- SPRY N/A
- Industry
- ROOT Property-Casualty Insurers
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- ROOT Finance
- SPRY Health Care
- Exchange
- ROOT Nasdaq
- SPRY Nasdaq
- Market Cap
- ROOT 1.2B
- SPRY 1.1B
- IPO Year
- ROOT 2020
- SPRY N/A
- Fundamental
- Price
- ROOT $88.82
- SPRY $9.05
- Analyst Decision
- ROOT Buy
- SPRY Strong Buy
- Analyst Count
- ROOT 6
- SPRY 4
- Target Price
- ROOT $124.40
- SPRY $31.25
- AVG Volume (30 Days)
- ROOT 489.5K
- SPRY 1.7M
- Earning Date
- ROOT 11-05-2025
- SPRY 11-10-2025
- Dividend Yield
- ROOT N/A
- SPRY N/A
- EPS Growth
- ROOT N/A
- SPRY N/A
- EPS
- ROOT 3.34
- SPRY N/A
- Revenue
- ROOT $1,446,800,000.00
- SPRY $112,339,000.00
- Revenue This Year
- ROOT $27.41
- SPRY N/A
- Revenue Next Year
- ROOT $9.74
- SPRY $193.13
- P/E Ratio
- ROOT $26.57
- SPRY N/A
- Revenue Growth
- ROOT 38.50
- SPRY 22367.80
- 52 Week Low
- ROOT $68.48
- SPRY $8.32
- 52 Week High
- ROOT $181.14
- SPRY $18.90
- Technical
- Relative Strength Index (RSI)
- ROOT 58.91
- SPRY 40.41
- Support Level
- ROOT $77.50
- SPRY $8.32
- Resistance Level
- ROOT $82.50
- SPRY $9.01
- Average True Range (ATR)
- ROOT 3.95
- SPRY 0.49
- MACD
- ROOT 1.38
- SPRY -0.05
- Stochastic Oscillator
- ROOT 91.11
- SPRY 35.57
About ROOT Root Inc.
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.